ProKidney
PROK
90 hedge funds and large institutions have $223M invested in ProKidney in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 7 closing their positions.
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
7% more funds holding
Funds holding: 84 → 90 (+6)
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
0.56% less ownership
Funds ownership: 89.97% → 89.42% (-0.56%)
1% less capital invested
Capital invested by funds: $225M → $223M (-$2.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIA
RP Investment Advisors
Toronto,
Ontario, Canada
|
+$5.33M |
| 2 |
LCM
LH Capital Markets
New York
|
+$4.94M |
| 3 |
CAC
Cowen and Company
New York
|
+$3.18M |
| 4 |
SC
Sculptor Capital
New York
|
+$1.64M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$5M |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
-$4.9M |
| 3 |
AC
Athanor Capital
New York
|
-$3.92M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.92M |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$1.84M |
PROK Hedge Fund Activity: Q4 2021 in Review
90 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q4 2021, worth a combined $223M — down 1.1% from $225M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new PROK positions and 7 closed out — a net gain of 6 holders — while 15 added to existing stakes and 15 trimmed.
The largest buyer was RP Investment Advisors, opening a new position worth an estimated $5.33M. The largest seller was BlueCrest Capital Management, cutting an estimated $5M.
- 90 institutional investors held ProKidney (PROK) as of Q4 2021, up from 84 in Q3 2021.
- Funds reported $223M of ProKidney stock for Q4 2021, down 1.1% quarter-over-quarter.
- 13 funds opened new ProKidney positions in Q4 2021 and 7 closed out, a net change of +6 holders.
- The largest ProKidney buyer in Q4 2021 was RP Investment Advisors, an estimated $5.33M added.
- The largest ProKidney seller in Q4 2021 was BlueCrest Capital Management, an estimated $5M sold.
Based on aggregated 13F filings for Q4 2021.